14-(4-methoxyphenyl)-7,8,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one

ID: ALA5283736

Max Phase: Preclinical

Molecular Formula: C25H21N3O2

Molecular Weight: 395.46

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(N2c3ccccc3C(=O)N3CCc4c([nH]c5ccccc45)C32)cc1

Standard InChI:  InChI=1S/C25H21N3O2/c1-30-17-12-10-16(11-13-17)28-22-9-5-3-7-20(22)25(29)27-15-14-19-18-6-2-4-8-21(18)26-23(19)24(27)28/h2-13,24,26H,14-15H2,1H3

Standard InChI Key:  NVDIUNUSIMNYJD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 35  0  0  0  0  0  0  0  0999 V2000
   -3.2308    1.6680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5162    2.0803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8044    1.6684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8044    0.8432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5144    0.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2308    0.8395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0197    0.5882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5346    1.2557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0196    1.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6839    2.6771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1367    2.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6217    2.0957    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860    1.3419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7709    0.6742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5916    0.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9273    1.5142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4424    2.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8549    2.8965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7455    1.5996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2308    0.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8984    0.1812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0789    0.0900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -0.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7708   -0.7552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3588   -1.4672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4666   -1.4672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8785   -0.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4703   -0.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8792   -2.1819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4666   -2.8965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  8  7  1  0
  9  8  2  0
  3  9  1  0
  9 10  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  1  0
 17 18  2  0
 16 19  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 15 22  1  0
 23 14  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
 26 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5283736

    ---

Associated Targets(Human)

GES1 (603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGC-27 (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.46Molecular Weight (Monoisotopic): 395.1634AlogP: 5.03#Rotatable Bonds: 2
Polar Surface Area: 48.57Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.71CX LogD: 4.71
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -0.17

References

1. Hao X, Deng J, Zhang H, Liang Z, Lei F, Wang Y, Yang X, Wang Z..  (2021)  Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents.,  55  [PMID:34990980] [10.1016/j.bmc.2021.116595]

Source